Detailed Information on Publication Record
2020
Multiple In vitro biological effects of phenolic compounds from Morus alba root bark
ČULENOVÁ, Marie, Alice SYCHROVÁ, S. T. S. HASSAN, K. BERCHOVA-BIMOVA, P. SVOBODOVA et. al.Basic information
Original name
Multiple In vitro biological effects of phenolic compounds from Morus alba root bark
Authors
ČULENOVÁ, Marie (203 Czech Republic, guarantor, belonging to the institution), Alice SYCHROVÁ (203 Czech Republic, belonging to the institution), S. T. S. HASSAN, K. BERCHOVA-BIMOVA, P. SVOBODOVA, A. HELCLOVA, H. MICHNOVA, J. HOSEK, H. VASILEV, Pavel SUCHÝ (203 Czech Republic, belonging to the institution), Gabriela KUZMÍNOVÁ (203 Czech Republic, belonging to the institution), Emil ŠVAJDLENKA (203 Czech Republic, belonging to the institution), Jan GAJDZIOK (203 Czech Republic, belonging to the institution), Alois ČÍŽEK (203 Czech Republic, belonging to the institution), Václav SUCHÝ (203 Czech Republic, belonging to the institution) and Karel ŠMEJKAL (203 Czech Republic, belonging to the institution)
Edition
JOURNAL OF ETHNOPHARMACOLOGY, CLARE, ELSEVIER IRELAND LTD, 2020, 0378-8741
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30104 Pharmacology and pharmacy
Country of publisher
Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 4.360
RIV identification code
RIV/00216224:14160/20:00118192
Organization unit
Faculty of Pharmacy
UT WoS
000503312800025
Keywords in English
Antiviral; Antibacterial; Anti-inflammatory; Docking; Mulberry; Phenolic
Tags
International impact, Reviewed
Změněno: 24/2/2021 08:19, Mgr. Hana Hurtová
Abstract
V originále
Ethnopharmacological relevance: Morus alba L. is used in traditional Chinese medicine for the treatment of various diseases, including bacterial infections and inflammation. As a rich source of phenolic compounds, the plant is an object of many phytochemical and pharmacological studies. Aim of the study: The aim of the study was to isolate and evaluate possible parallel antiviral, antibacterial, and anti-inflammatory activities of phenolic mulberry compounds. Materials and methods: Extensive chromatographic separation of mulberry root bark extract and in vitro biological screening of 26 constituents identified promising candidates for further pharmacological research. Selected compounds were screened for anti-infective and anti-inflammatory activities. Antiviral activity was determined by the plaque number reduction assay and by the titer reduction assay, antibacterial using broth microdilution method, and anti-inflammatory activity using COX Colorimetric inhibitor screening assay kit. One compound was evaluated in vivo in carrageenan-induced paw-edema in mice. Results: Five prenylated compounds 1, 2, 8, 9, and 11, together with a simple phenolic ester 13, exhibited inhibitory activity against the replication of herpes simplex virus 1 (HSV-1) or herpes simplex virus 2 (HSV-2), with IC50 values ranging from 0.64 to 1.93 mu g/mL, and EC50 values 0.93 and 1.61 mu g/mL. Molecular docking studies demonstrated the effects of the active compounds by targeting HSV-1 DNA polymerase and HSV-2 protease. In antibacterial assay, compounds 1, 4, 11, and 17 diminished the growth of all of the Gram-positive strains tested, with MIC values of 1-16 mu g/mL. The anti-inflammatory ability of several compounds to inhibit cyclooxygenase 2 (COX-2) was tested in vitro, and compound 16 displayed greater activity than the indomethacin, positive control. Mulberrofuran B (11) showed anti-inflammatory activity in vivo against carrageenan-induced paw-edema in mice. Conclusions: Experimental investigation showed promising antiviral, antibacterial, and/or anti-inflammatory activities of the phenolic mulberry constituents, often with multiple inhibitory effects that might be used as a potential source of new medicine.